FDA Inspection 1205573 — IVF Hawaii, Inc. dba IVF Hawaii
The FDA completed an inspection of IVF Hawaii, Inc. dba IVF Hawaii on May 2, 2023 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 2, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Honolulu, HI (United States)